Anzeige
Mehr »
Login
Sonntag, 24.01.2021 Börsentäglich über 12.000 News von 656 internationalen Medien
Breaking News! Christina Lake Cannabis: Blendende Aussichten für 2021 - Rock and Roll!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
SaFast on GlaxoSmithKline's heels, Aurinia wins OK to steer a second lupus nephritis drug straight to the market
FrYale cancer specialist Charlie Fuchs tapped as new global development chief for Roche/Genentech
FrNeuvogen uncloaks with broad plan of attack for whole-cell cancer vaccines, clinical hopes within the year
FrNews briefing: Eli Lilly completes $1B+ Prevail buyout; Elzonris approved in Europe for adults
FrFlush with cash to change the generics supply chain, Civica Rx looks to break ground on first in-house manufacturing site
FrCan a new CRISPR technique unlock the secrets of how cancer spreads?
FrDiem Nguyen tapped to lead 'point of inflection' at Xalud Therapeutics; Diana Escolar dances her way to Avrobio CMO
FrWhat does $29B buy you in Big Pharma? In GlaxoSmithKline's case, a whole lot of uncomfortable questions about the pipeline
FrBiden institutes regulatory freeze on first day of presidency
FrIncyte's PD-1 priority review draws muted applause - but analysts say it's all about getting a foot in the door
FrGlaxoSmithKline scraps a LAG3 study, marking another failure for the pipeline after a critical setback
FrCovid-19 roundup: Pfizer/BioNTech will reportedly supply vaccines to COVAX as Poland threatens lawsuit over shortfalls
DoAfter stinging FDA setback, GlaxoSmithKline's ViiV finally notches US approval for long-acting HIV injection
DoMonths after a major rebranding around CAR-NKT cells, Kuur Therapeutics is offering a peek at early results
DoDeval Patrick joins Cerevel board, further intertwining company with Bain Capital
DoNorthway Biotech sets up shop in Boston hub, looking to court more customers with biologics-focused plant
DoNews briefing: Five public biotechs, over 2 days, raise $883M from fresh offerings; Belgian biotech expands Series B funding
DoCovid-19 roundup: Italy wonders aloud if it can sue Pfizer for vaccine shortfalls; US recommits to WHO under Biden administration
DoPlexium adds industry vet Mike Grey to the brain trust with new investor cash funding its protein degradation play
DoEli Lilly's antibody cuts risk of Covid-19 by up to 80% among the most vulnerable - but will it have a place next to vaccines?
DoEndpoints poll: Janet Woodcock takes the (interim) helm at the FDA. And a large majority of our readers want her to stay there
DoWith patent concerns looming, Roche gets a new priority review on blockbuster IPF drug
DoBIO looks to restructure, laying off staff amid challenge to the trade org's normal face-to-face style
DoWhat's next for Endpoints - and how to support our independent biopharma news mission
DoFDA guides on Covid-19 considerations in cell and gene therapy